Use of advanced heart failure therapies in Duchenne muscular dystrophy
Carol Wittlieb‐Weber(Children's Hospital of Philadelphia), Kenneth R. Knecht(Arkansas Children's Hospital), Katheryn Gambetta(Northwestern University), Chet Villa(Cincinnati Children's Hospital Medical Center), Jonathan N. Johnson, Shawn C. West(Children's Hospital of Pittsburgh), M.J. Bock, Irene D. Lytrivi(Morgan Stanley Children's Hospital), Michael A. McCulloch(University of Virginia Children's Hospital), Sabrina Law(Morgan Stanley Children's Hospital), Kurt R. Schumacher(University of Michigan), Jennifer Conway(University of Alberta), David R. Weber(Children's Hospital of Philadelphia), Ashwin K. Lal(Children's Hospital at Montefiore), Joshua Friedland‐Little(Seattle Children's Hospital), Shriprasad R. Deshpande(George Washington University Hospital), Ryan J. Butts(The University of Texas Southwestern Medical Center)
Cited by 20
Related Papers
The Functional Independence Measure: A comparative validity and reliability study
|Disability and Rehabilitation|1995|527
Tbx5-Hedgehog Molecular Networks Are Essential in the Second Heart Field for Atrial Septation
|Developmental Cell|2012|168
sonic hedgehog is required in pulmonary endoderm for atrial septation
|Development|2009|157
Results of the FUEL Trial
|Circulation|2019|157
Cardiac Management of the Patient With Duchenne Muscular Dystrophy
|PEDIATRICS|2018|123